Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients

Epidemiology and Infection

Volumn 141, Issue 11, 2013, Pages 2392-2402

  Delorenze, G N ^a   Horberg, M A ^b   Silverberg, M J ^a   Tsai, A ^a   Quesenberry, C P ^a   Baxter, R ^c  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

aureus (MRSA); Epidemiology; HIV AIDS; incidence; methicillin resistant S

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL LOAD; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIXED INFECTION; SCHOOL CHILD; SEASONAL VARIATION; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGING; CALIFORNIA; CHILD; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS; YOUNG ADULT;

EID: 84885025016     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813000228     Document Type: Article

References (41)

1. National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1992 to June 2002, issued August 2002. American Journal of Infection Control 2002; 30: 458-475.
2. Barrett FF, McGehee RF Jr., Finland M. Methicillinresistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. New England Journal of Medicine 1968; 279: 441-448.
3. CDC. Methicillin-resistant Staphylococcus aureus infections in correctional facilities -Georgia, California, and Texas, 2001-2003. Morbidity and Mortality Weekly Report 2003; 52: 992-996.
4. CDC. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants -Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. Morbidity and Mortality Weekly Report 2003; 52: 793-795.
5. CDC. Outbreaks of community-associated methicillinresistant Staphylococcus aureus skin infections -Los Angeles County, California, 2002-2003. Morbidity and Mortality Weekly Report 2003; 52: 88.
6. Diekema DJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases 2001; 32 (Suppl. 2): S114-S132.
7. Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. Journal of the Acquired Immune Deficiency Syndrome and Human Retrovirology 1995; 8: 51-57.
8. Northfelt DW, Polsky B. Bacteremia in persons with HIV infection. AIDS Clinical Reviews 1991; 1: 59-79.
9. Senthilkumar A, Kumar S, Sheagren JN. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clinical Infectious Diseases 2001; 33: 1412-1416.
10. Alonso R, et al. Outbreak among HIV-infected patients of Staphylococcus aureus resistant to cotrimoxazole and methicillin. Infection Control and Hospital Epidemiology 1997; 18: 617-621.
11. Anderson EJ, et al. A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. Journal of Acquired Immune Deficiency Syndrome 2006; 41: 125-127.
12. Bar A, et al. Spectrum of bacterial isolates in HIVpositive patients with skin and soft tissue infections: emergence of methicillin-resistant Staphylococci. AIDS 2003; 17: 1253-1256.
13. Eulalia VM, et al. Nosocomial infection with methicillin resistant Staphylococcus aureus in 14 human immunodeficiency virus infected patients. Medicina Clínica (Barcelona) 1997; 109: 261-263.
14. Gordon RJ, et al. A molecular epidemiological analysis of 2 Staphylococcus aureus clonal types colonizing and infecting patients with AIDS. Clinical Infectious Diseases 2005; 40: 1028-1036.
15. Klein PA, et al. Prevalence of methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Archives of Dermatology 1997; 133: 1463-1465.
16. Lee NE, et al. Risk factors for community-associated methicillin- resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clinical Infectious Diseases 2005; 40: 1529-1534.
17. Mathews WC, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. Journal of Acquired Immune Deficiency Syndrome 2005; 40: 155-160.
18. McDonald LC, et al. Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. International Journal of STD & AIDS 2003; 14: 473-477.
19. Shet A, et al. Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1. Journal of Infectious Diseases 2009; 200: 88-93.
20. Sztramko R, et al. Community-associated methicillinresistant Staphylococcus aureus infections in men who have sex with men: a case series. Canadian Journal of Infectious Disease and Medical Microbiology 2007; 18: 257-261.
21. Skiest DJ, et al. Prospective comparison of methicillinsusceptible and methicillin-resistant communityassociated Staphylococcus aureus infections in hospitalized patients. Journal of Infection 2007; 54: 427-434.
22. Skiest D, et al. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Medicine 2006; 7: 361-368.
23. Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 1763-1771.
24. Popovich KJ, et al. Community-associated methicillinresistant Staphylococcus aureus and HIV: intersecting epidemics. Clinical Infectious Diseases 2010; 50: 979-987.
25. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. American Journal of Public Health 1992; 82: 703-710.
26. Rosario-Rosado RV, Rene AA, Jones B. Descriptive analysis of patients with community-onset and hospital-onset methicillin-resistant Staphylococcus aureus infections. Infection Control and Hospital Epidemiology 2004; 25: 171-173.
27. Kempker RR, et al. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. Journal of Infection 2010; 61: 372-381.
28. Davis SL, et al. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology 2006; 27: 1025-1031.
29. Teutsch SM, Churchill RE. Principles and Practice of Public Health Surveillance, 2nd edn. Oxford University Press, 2000.
30. Kallen AJ, et al. Health care-associated invasive MRSA infections, 2005-2008. Journal of the American Medical Association 2010; 304: 641-648.
31. Kupfer M, et al. MRSA in a large German University Hospital: male gender is a significant risk factor for MRSA acquisition. GMS Krankenhaushygiene Interdisziplinär 2010; 5: 1-8.
32. King MD, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals of Internal Medicine 2006; 144: 309-317.
33. Padoveze MC, et al. Nasal MRSA colonization of AIDS Patients cared for in a Brazilian university hospital. Infection Control and Hospital Epidemiology 2001; 22: 783-785.
34. Peters PJ, et al. Methicillin-resistant Staphylococcus aureus colonization in HIV-infected outpatients is common and detection is enhanced by groin culture. Epidemiology and Infection 2011; 139: 998-1008.
35. Crum-Cianflone NF, et al. Association of methicillinresistant Staphylococcus aureus (MRSA) colonization with high-risk sexual behaviors in persons infected with Human Immunodeficiency Virus (HIV). Medicine (Baltimore) 2011; 90: 379-389.
36. Chacko J, Kuruvila M, Bhat GK. Factors affecting the nasal carriage of methicillin-resistant Staphylococcus aureus in human immunodeficiency virus-infected patients. Indian Journal of Medical Microbiology 2009; 27: 146-148.
37. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clinical Microbiology Reviews 1997; 10: 505-520.
38. Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. International Journal of STD & AIDS 2007; 18: 521-526.
39. Liu C, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clinical Infectious Diseases 2008; 46: 1637-1646.
40. Office of the Associate Director for Communication. CDC steps up efforts to fight drug-resistant germ. Centers for Disease Control and Prevention, Press release, 8 September 2008 (http://www.cdc.gov/media/pressrel/2008/r080908.htm).
41. Herwaldt LA. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. American Journal of Medicine 1999; 106 (Suppl. 1): S8-S11.